作者: Eric Peter Thelin , Adel Helmy , David W. Nelson , Niklas Marklund
关键词:
摘要: Brain injuries can be caused by, for instance, spontaneous hemorrhages, thromboembolic incidents or traumatic events, and are considerable sources of morbidity mortality (1). commonly result in immense socioeconomic consequences due to the acute as well persisting neurological deficits (2). To date, there currently few pharmacological therapies proven clinical benefit targeting underlying pathophysiology occurring aftermath subarachnoid hemorrhage (SAH) (3), stroke (4), brain injury (TBI) (5). Although these exceedingly heterogeneous, some common pathophysiological phases may identified. At disease onset, primary ictus cause initial neuronal, glial, vascular injury, which is then followed by complex responses. The tissue exacerbated secondary insults, vulnerable during first post-injury period (6). cascades include among others neuroinflammation, energy failure, hypoxia, inadequate cerebral perfusion (7). By monitoring multiple intracerebral systemic parameters across a range modalities, time course detrimental ascertained. Importantly, knowledge acquired from investigation processes expected facilitate future development novel treatment strategies. Recently, improved intracranial was stressed one key areas research commissioned article devoted TBI Lancet Neurology editorial (8). In this Research Topic, number authors several centers excellence worldwide have shared their on injuries. These contributions provide updated other injuries, refining patient management overall goal improving outcomes detection deleterious injured brain.